Yield10 Bioscience Profit Margin

Yield10 Bioscience (YTEN) currently reports a profit margin of -1568.15% as of June 2024. That compares with -5518.22% in the prior-year period — up 71.6% year over year. That is below the Consumer Discretionary sector average of 10.32%. Use the charts on this page to explore Yield10 Bioscience's profit margin history and peer comparisons.

Yield10 Bioscience's profit margin increased from -5518.22% to -1568.15% — a 71.6% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Yield10 Bioscience's profit margin of -1568.15% is lower than the Consumer Discretionary sector average of 10.32%. That is roughly 15298.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Yield10 Bioscience's current -1568.15% should be judged against Consumer Discretionary norms (sector average: 10.32%) and against YTEN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1568.15%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Consumer Discretionary average is 10.32%. From there, open related valuation or income-statement pages for Yield10 Bioscience, and consider following YTEN for alerts when major investors trade the stock.